Wellspring Financial Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$532K Buy
4,213
+216
+5% +$28.5K 0.04% 160
2026
Q1
$557K Sell
3,997
-184
-4% -$25.8K 0.04% 154
2025
Q4
$514K Buy
+4,181
New +$508K 0.04% 141

Other funds holding GILD

Wellspring Financial Advisors's GILD Position: Q2 2026 in Review

Wellspring Financial Advisors increased its Gilead Sciences (GILD) stake by 5.4% in Q2 2026, buying an estimated $28.5K and bringing the position to 4,213 shares worth $532K. The position accounts for 0.04% of the portfolio, ranked #160.

Wellspring Financial Advisors first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $557K in Q1 2026. 691 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wellspring Financial Advisors held 4,213 shares of Gilead Sciences worth $532K as of Q2 2026.
  • Wellspring Financial Advisors bought 216 Gilead Sciences shares in Q2 2026, an estimated $28.5K.
  • Gilead Sciences made up 0.04% of Wellspring Financial Advisors's portfolio in Q2 2026, its #160 holding.
  • Wellspring Financial Advisors first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Wellspring Financial Advisors's Gilead Sciences position peaked at $557K in Q1 2026.
  • 691 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wellspring Financial Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.